How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Antibody Purification Services Market
- By Purification Technique: Protein A Affinity Chromatography, Protein G Affinity Chromatography, Ion Exchange Chromatography, Size Exclusion Chromatography, Hydrophobic Interaction Chromatography
- By Antibody Type: Monoclonal Antibody Purification, Polyclonal Antibody Purification, Recombinant Antibody Purification, Bispecific Antibody Purification, Antibody Fragment Purification
- By End-Use Industry: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs), Veterinary and Animal Health
- By Service Model: Custom Antibody Purification Services, Standardized Antibody Purification Kits, Process Development and Optimization, Analytical and Quality Control Services, Scale-Up and Manufacturing Support
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Protein A Affinity Chromatography leads By Purification Technique at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Antibody Purification Services Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Purification Technique 5
Antibody Type 5
End-Use Industry 5
Service Model 5
Companies profiled
GE Healthcare Life Sciences (Cytiva)
Thermo Fisher Scientific
Merck KGaA (MilliporeSigma)
Bio-Rad Laboratories
Sartorius AG
Agilent Technologies
Repligen Corporation
Pall Corporation (part of Danaher)
Abcam plc
Bio-Techne Corporation
Cytiva (formerly part of GE Healthcare)
Takara Bio Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →GE Healthcare Life Sciences (Cytiva)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Agilent Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Repligen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Pall Corporation (part of Danaher)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Abcam plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Bio-Techne Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cytiva (formerly part of GE Healthcare)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Takara Bio Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Protein A/G/L suppliers like GenScript
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Pierce Biotechnology (Thermo Fisher brand)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Chromatography resin manufacturers specializing in antibody purification
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,386M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Protein A Affinity Chromatography48.6
- Protein G Affinity Chromatography14.7
- Ion Exchange Chromatography13.3
- Size Exclusion Chromatography15.8
- Hydrophobic Interaction Chromatography7.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$895.7M → $1,981M · 10.4%
Europe$624.3M → $1,112M · 7.5%
Asia Pacific$570.0M → $1,075M · 8.3%
Latin America$352.9M → $779.4M · 10.4%
Middle East and Africa$271.4M → $548.6M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.892026
8.912027
8.922028
8.942029
8.952030
8.952031
8.972032
8.992033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- GE Healthcare Life Sciences (Cytiva)22.2
- Thermo Fisher Scientific16.1
- Merck KGaA (MilliporeSigma)7.1
- Bio-Rad Laboratories9.5
- Sartorius AG10.1
- Agilent Technologies7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Purification Technique37.5%
Antibody Type19.4%
End-Use Industry20.9%
Service Model22.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.0
- Europe20.2
- Asia Pacific19.6
- Latin America14.2
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| GE Healthcare Life Sciences (Cytiva) | 98 | 98 | 95 | 95 | 79 | 81 | 91 |
| Thermo Fisher Scientific | 78 | 78 | 90 | 86 | 83 | 69 | 81 |
| Merck KGaA (MilliporeSigma) | 76 | 85 | 85 | 80 | 84 | 84 | 82 |
| Bio-Rad Laboratories | 64 | 74 | 62 | 58 | 81 | 81 | 70 |
| Sartorius AG | 67 | 64 | 64 | 74 | 74 | 73 | 69 |
| Agilent Technologies | 51 | 51 | 69 | 67 | 55 | 55 | 58 |
| Repligen Corporation | 41 | 41 | 63 | 47 | 44 | 53 | 48 |
| Pall Corporation (part of Danaher) | 56 | 42 | 35 | 35 | 35 | 51 | 42 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- GE Healthcare Life Sciences (Cytiva)
- Thermo Fisher Scientific
- Merck KGaA (MilliporeSigma)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| GE Healthcare Life Sciences (Cytiva) | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Thermo Fisher Scientific | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Merck KGaA (MilliporeSigma) | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Bio-Rad Laboratories | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Sartorius AG | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Agilent Technologies | − | − | ◐ | ✓ | ◐ | ◐ |
| Repligen Corporation | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Pall Corporation (part of Danaher) | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1GE Healthcare Life Sciences (Cytiva)91
2Merck KGaA (MilliporeSigma)82
3Thermo Fisher Scientific81
4Bio-Rad Laboratories70
5Sartorius AG69
6Agilent Technologies58
7Repligen Corporation48
8Pall Corporation (part of Danaher)42
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
GE Healthcare Life Sciences (Cytiva)Thermo Fisher ScientificMerck KGaA (MilliporeSigma)
Challenger2
Strong scale, closing on the leaders.
Bio-Rad LaboratoriesSartorius AG
Contender1
Focused players with pockets of strength.
Agilent Technologies
Niche2
Specialists in a single segment or region.
Repligen CorporationPall Corporation (part of Danaher)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Purification Technique in North America, then scale across Antibody Purification Services Market — a $532M beachhead inside a $8.98B market.
Beachhead (SOM)$532Mobtainable near-term
Serviceable (SAM)$3.59Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Protein A Affinity Chromatography
Best fit — highest urgency & budget in Purification Technique.
Economic buyer76 fit
Protein G Affinity Chromatography
Strong fit — clear ROI and a fast path to value.
End user64 fit
Ion Exchange Chromatography
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Purification Technique in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Antibody Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-Use Industry
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Purification Technique leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Antibody Purification Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation14%
Closed-won8%
$8.7KCAC
$33KLTV
3.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Antibody Purification Services Market is a durable-growth opportunity — $6.01B by 2033, compounding at 8.9%.
TAM · 2025$3.04Btoday
TAM · 2033$6.01Bforecast
CAGR8.9%2027–2033
Cumulative$39.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.01BTotal addressable market
SAM$2.05BServiceable available market
SOM$344MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.9% CAGR
Demand compounds through 2033, outpacing GDP across Purification Technique.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Purification Technique moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.01BLarge & growingTAM by 2033 at 8.9% CAGR
$2.05BServiceable nowreachable with today’s model
$344MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.69BBear5.8% CAGR
$6.01BBase8.9% CAGR
$7.70BBull11.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Antibody Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Antibody Purification Services Market — a $1.28B market by 2033. Plan: grow share from 9.0% to 16.3%.
Market size · 2033$1.28Btotal addressable
Market CAGR10.7%2027–2033
Target share16.3%from 9.0% today
Revenue ambition$209Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 16.3% | At risk |
| Revenue | $112M | $209M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 30.3% | 45.3% | On track |
| Customer retention | 85.9% | 92.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Purification Technique
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Antibody Type capability
A defensible second engine — invest in Antibody Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Purification Technique share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Antibody Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $30M capacity & capability investment
- Greenlight bolt-on M&A in Antibody Type
- Authorise North America expansion plan
- Fund R&D program for Purification Technique leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Antibody Purification Services Market conversation — a $3.31B market you can size, segment and defend in minutes.
Market size · 2033$3.31Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,110+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Purification Technique
Goal Grow share in Purification Technique
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 4 mopayback period
$90K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
GE Healthcare Life Sciences (Cytiva)Thermo Fisher ScientificMerck KGaA (MilliporeSigma)Bio-Rad LaboratoriesSartorius AGAgilent TechnologiesRepligen CorporationPall Corporation (part of Danaher)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Antibody Purification Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Antibody Purification Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Treatment Chairs Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportAntibody Purification Kits Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportCreatinine Meter Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportAntibody Pairing Service Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportCapsule Filler Machine Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportAntibody Microarrays Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportMedical Tray Sealing Machine Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportAntibody Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportAllergy Tester Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportAntibody Library Technology Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportPlastic Sterilization Tray Market
Market size, share, segmentation and regional forecast.
$547M market · 2025 base year
View reportAutomated Compounding System Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.